Region:Middle East
Author(s):Geetanshi
Product Code:KRAC3080
Pages:90
Published On:October 2025
By Drug Class:The market is segmented into various drug classes, including Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors (IL-17, IL-12/23, IL-23), Vitamin D Analogues, Corticosteroids, Retinoids, Calcineurin Inhibitors, and Others. Among these, TNF Inhibitors and Interleukin Inhibitors are leading the market due to their effectiveness in treating moderate to severe psoriasis. The increasing adoption of biologics and targeted therapies, particularly in the form of self-injectable and long-acting agents, is contributing to the growth of these segments .
By Route of Administration:The market is categorized based on the route of administration, which includes Oral, Topical, and Injectable forms. Injectable treatments, particularly biologics, are gaining traction due to their rapid efficacy and convenience for patients with severe psoriasis. Topical treatments remain popular for mild to moderate cases, while oral medications are also widely used, contributing to the overall market dynamics .
The Middle East Psoriasis Drugs Market is characterized by a dynamic mix of regional and international players. Leading participants such as AbbVie Inc., Amgen Inc., Novartis AG, Johnson & Johnson (Janssen Biotech Inc.), Pfizer Inc., Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A., Galderma S.A., UCB S.A., Stiefel Laboratories, Inc. (a GSK company), Takeda Pharmaceutical Company Limited, Sandoz International GmbH (Novartis division), Celgene Corporation (a Bristol Myers Squibb company), Janssen Biotech, Inc. (Johnson & Johnson subsidiary) contribute to innovation, geographic expansion, and service delivery in this space.
The future of the Middle East psoriasis drugs market appears promising, driven by ongoing advancements in treatment options and increasing healthcare investments. The region is likely to see a surge in personalized medicine approaches, enhancing treatment efficacy. Additionally, the integration of telemedicine is expected to improve patient access to dermatological care, facilitating timely interventions. As healthcare systems evolve, the focus on patient-centric care will further shape the market landscape, fostering innovation and improving patient outcomes.
| Segment | Sub-Segments |
|---|---|
| By Drug Class | Tumor Necrosis Factor (TNF) Inhibitors Interleukin Inhibitors (IL-17, IL-12/23, IL-23) Vitamin D Analogues Corticosteroids Retinoids Calcineurin Inhibitors Others |
| By Route of Administration | Oral Topical Injectable |
| By Distribution Channel | Retail Pharmacies Hospital Pharmacies Online Pharmacies |
| By Country | Saudi Arabia United Arab Emirates Qatar Turkey Egypt Rest of Middle East |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Dermatology Clinics | 100 | Dermatologists, Clinic Managers |
| Pharmacies | 80 | Pharmacists, Pharmacy Owners |
| Patient Advocacy Groups | 60 | Patient Representatives, Healthcare Advocates |
| Healthcare Providers | 90 | General Practitioners, Healthcare Administrators |
| Insurance Companies | 50 | Health Insurance Analysts, Policy Makers |
The Middle East Psoriasis Drugs Market is valued at approximately USD 1.3 billion, reflecting a significant growth driven by the rising prevalence of psoriasis and advancements in drug formulations, particularly biologics and targeted therapies.
What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.
